The pharmaceutical market in the Czech Republic is strongly competitive with numerous foreign companies. There were 90 active companies in 2017, up from 80 in 2014. Foreign players dominate the market due to the high costs related to drug production, especially that of patented drugs. The pharmaceutical industry is among the sectors with high R&D costs, which accounted for about 15%- 20% of the annual revenues of the sector, according to the Ministry of Industry and Trade.

01 EXECUTIVE SUMMARY 

02 SECTOR IN FOCUS 

03 COMPETITIVE LANDSCAPE 

04 COMPANIES IN FOCUS

05 REGULATORY ENVIRONMENT 

06 HEALTHCARE SERVICES 

07 PRESCRIPTION DRUGS 

08 OVER-THE-COUNTER DRUGS 

09 RETAIL CHANNELS